Affordable Access

[Therapeutic efficacy and prognostic factors of sorafenib treatment in patients with unresectable primary hepatocellular carcinoma].

Authors
  • Zhang, Lan
  • Ren, Zheng-gang
  • Gan, Yu-hong
  • Wang, Yan-hong
  • Zhang, Bo-heng
  • Chen, Yi
  • Xie, Xiao-ying
  • Ge, Nin-ling
  • Ye, Sheng-long
Type
Published Article
Journal
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Publication Date
Aug 01, 2010
Volume
32
Issue
8
Pages
630–633
Identifiers
PMID: 21122420
Source
Medline
License
Unknown

Abstract

Soafenib is effective for unresectable primary HCC with tolerable toxicity. Tumor stage is a predominant prognostic factor.

Report this publication

Statistics

Seen <100 times